5l1q
From Proteopedia
(Difference between revisions)
m (Protected "5l1q" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==X-ray Structure of Cytochrome P450 PntM with Dihydropentalenolactone F== | |
+ | <StructureSection load='5l1q' size='340' side='right' caption='[[5l1q]], [[Resolution|resolution]] 2.03Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[5l1q]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5L1Q OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5L1Q FirstGlance]. <br> | ||
+ | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7DF:DIHYDROPENTALENOLACTONE+F'>7DF</scene>, <scene name='pdbligand=HEM:PROTOPORPHYRIN+IX+CONTAINING+FE'>HEM</scene></td></tr> | ||
+ | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5l1o|5l1o]], [[5l1p|5l1p]], [[5l1r|5l1r]], [[5l1s|5l1s]], [[5l1t|5l1t]], [[5l1u|5l1u]], [[5l1v|5l1v]], [[5l1w|5l1w]]</td></tr> | ||
+ | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Pentalenolactone_synthase Pentalenolactone synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.19.8 1.14.19.8] </span></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5l1q FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l1q OCA], [http://pdbe.org/5l1q PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5l1q RCSB], [http://www.ebi.ac.uk/pdbsum/5l1q PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5l1q ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | The final step in the biosynthesis of the sesquiterpenoid antibiotic pentalenolactone (1) is the highly unusual cytochrome P450-catalyzed, oxidative rearrangement of pentalenolactone F (2), involving the transient generation and rearrangement of a neopentyl cation. In Streptomyces arenae this reaction is catalyzed by CYP161C2 (PntM), with highly conserved orthologues being present in the pentalenolactone biosynthetic gene clusters of at least 10 other Actinomycetes. The 2.00 - 2.28 A crystal structures of substrate-free PntM, as well as PntM with bound substrate 2, product 1, and substrate analogue 6,7-dihydropentalenolactone F (7) have revealed the close interaction of bound ligand with three active site residues, F232, M77, and M81 that are unique to PntM and its orthologues and absent from essentially all other P450s. Site-directed mutagenesis, ligand-binding measurements, steady-state kinetics, and reaction product profiles have established there is no special stabilization of reactive cationic intermediates by any of these side chains. Reduced substrate analogue 7 did not undergo either oxidative rearrangement or simple hydroxylation, suggesting that the C1 carbocation is not anchimerically stabilized by the 6,7-double bond of 2. The crystal structures also revealed plausible proton relay networks likely involved in the generation of the key characteristic P450 oxidizing species, Compound I, and in mediating stereospecific deprotonation of H-3re of the substrate. We conclude that the unusual carbocation intermediate results from outer shell electron transfer from the transiently generated C1 radical to the tightly paired heme- *Fe3+-OH radical species. The oxidative electron transfer is kinetically dominant as a result of the unusually strong steric barrier to oxygen rebound to the neopentyl center C-1si which is flanked on each neighboring carbon by syn-axial substituents. | ||
- | + | The Cytochrome P450-Catalyzed Oxidative Rearrangement in the Final Step of Pentalenolactone Biosynthesis: Substrate Structure Determines Mechanism.,Duan L, Jogl G, Cane DE J Am Chem Soc. 2016 Sep 2. PMID:27588339<ref>PMID:27588339</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | [[Category: | + | </div> |
- | [[Category: | + | <div class="pdbe-citations 5l1q" style="background-color:#fffaf0;"></div> |
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Pentalenolactone synthase]] | ||
+ | [[Category: Cane, D E]] | ||
[[Category: Duan, L]] | [[Category: Duan, L]] | ||
- | [[Category: | + | [[Category: Jogl, G]] |
+ | [[Category: Cytochrome p450]] | ||
+ | [[Category: Dihydropentalenolactone f]] | ||
+ | [[Category: Oxidoreductase]] | ||
+ | [[Category: Pntm]] |
Revision as of 15:20, 14 September 2016
X-ray Structure of Cytochrome P450 PntM with Dihydropentalenolactone F
|